Close

Craig-Hallum Downgrades ArthroCare (ARTC) to Hold

Go back to Craig-Hallum Downgrades ArthroCare (ARTC) to Hold

BMO Capital Downgrades ArthroCare (ARTC) to Market Perform

February 18, 2014 7:55 AM EST

BMO Capital downgraded ArthroCare (NASDAQ: ARTC) from Outperform to Market Perform with a price target of $48.25 (from $43.00).

For an analyst ratings summary and ratings history on ArthroCare click here. For more ratings news on ArthroCare click here.

Shares of ArthroCare closed at $48.67 yesterday, with a 52 week range of $31.56-$49.95.... More